Akorn Recalls Sulfacetamide Sodium Ophthalmic Solution Due to Sterility Concerns
Akorn, Inc. is recalling specific lots of Sulfacetamide Sodium Ophthalmic Solution because they failed antimicrobial effectiveness testing, raising concerns about sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an ophthalmic product, which poses a significant risk of serious injury or infection.
Plain-English summary
Akorn, Inc. is recalling 57,920 bottles of Sulfacetamide Sodium Ophthalmic Solution, USP, 10%, Sterile, Rx Only, 15 mL bottles (NDC 17478-221-12). The recall involves three specific lots: Lot# 5A17A (Expiry 06/16), Lot# 5K21A (Expiry 03/17), and Lot# 6A08A (Expiry 06/17). The product was distributed nationwide and in Puerto Rico.
The recall was initiated due to a lack of assurance of sterility. Specifically, some lots failed Antimicrobial Effectiveness Testing on stability. This testing failure suggests that the preservative system may not be effective in maintaining the sterility of the product over time.
Consumers and healthcare providers should stop using the affected lots immediately. Patients should consult their healthcare provider for alternative treatment options. The recalling firm is Akorn, Inc., located in Lake Forest, IL.
The recalled product
- Product
- Sulfacetamide Sodium Ophthalmic Solution, USP, 10%, Sterile, Rx Only, 15 mL bottles, Mfd. by: Akorn, Inc., Lake Forest, IL 60045 --- NDC 17478-221-12
- Manufacturer
- Akorn, Inc.
- Category
- Drug — Ophthalmic
- Affected units
- 57,920
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot# 5A17A
- Expiry 06/16 Lot# 5K21A
- Expiry 03/17 Lot# 6A08A
- Expiry 06/17
Distribution
Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- LowAkorn Recalls Atropine Sulfate Ophthalmic Solution Due to Viscosity Failure
FDA (Drugs) · 2018-03-14
- SevereAkorn Recalls Phenylephrine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereAkorn Recalls Gentamicin Sulfate Ophthalmic Solution Due to Impurities
FDA (Drugs) · 2019-03-20
- ModerateAkorn Atropine Sulfate Eye Solution Recalled for Failed Stability Testing
FDA (Drugs) · 2023-02-15
- ModerateAkorn Recalls Subpotent Sodium Chloride Ophthalmic Solution
FDA (Drugs) · 2016-11-09
- SevereAkorn Recalls Latanoprost Ophthalmic Solution Due to Sterility Assurance Issues
FDA (Drugs) · 2017-04-19